Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00799812 · ClinicalTrials.gov registry record · Phase 3
Test for Pre Operative Skin Preparations
A Phase 3 study of Topical Antisepsis, sponsored by C. R. Bard.
- Completed
- Registry status
- Phase 3
- Development phase
- 335
- Enrollment target
- 1
- Study location
NCT00799812 is a Phase 3 study of Topical Antisepsis that has completed, run by C. R. Bard. The registered enrollment target is 335 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00799812, a Phase 3 study of Topical Antisepsis, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 335 participants
- Enrollment target
- 1
- Study location
Study Summary
Compare 2 application techniques of ChloraPrep Swabstick--3 swabsticks at once versus 3 swabsticks used sequentially. Hibiclens applied according to the manufacturer's directions. Sterile swabsticks (wetted with sterile deionizd water) applied using the same method as the ChloraPrep Swabstick.
Conditions Studied
Interventions
- DRUG CHG 2% w/v & IPA 70% v/v, swabstick (3 @ once).
- DRUG CHG 2% w/v & IPA 70% v/v swab applied sequentially
- DRUG Aqueous CHG 4% w/v applied according to mfr's directions
- OTHER Sterile swabstick with sterile water (3 @ once)
- OTHER Sterile swabstick with sterile water (one-at-a-time)
Study Locations (1)
Virginia
- Microbiotest - Sterling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 335 participants |
| Start Date | 2007-11-13 |
| Est. Completion | 2008-06-19 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00799812
The ClinicalTrials.gov registry entry for NCT00799812 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 335 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Topical Antisepsis appearing as the primary indexed condition, and to 5 interventions - of which CHG 2% w/v & IPA 70% v/v, swabstick (3 @ once). is the first listed.
NCT00799812 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT00799812 about?
NCT00799812 is a clinical study titled "Test for Pre Operative Skin Preparations". Compare 2 application techniques of ChloraPrep Swabstick--3 swabsticks at once versus 3 swabsticks used sequentially. Hibiclens applied according to the manufacturer's directions. Sterile swabsticks (wetted with sterile deionizd water) applied using the same method as the ChloraPrep Swabstick.
What is the current status of trial NCT00799812?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 335 participants. The study started on 2007-11-13. Estimated completion is 2008-06-19.
What conditions does trial NCT00799812 study?
This clinical trial studies the following conditions: Topical Antisepsis.
What interventions are being tested in trial NCT00799812?
The interventions under investigation include: CHG 2% w/v & IPA 70% v/v, swabstick (3 @ once). (DRUG), CHG 2% w/v & IPA 70% v/v swab applied sequentially (DRUG), Aqueous CHG 4% w/v applied according to mfr's directions (DRUG), Sterile swabstick with sterile water (3 @ once) (OTHER), Sterile swabstick with sterile water (one-at-a-time) (OTHER).
Who is sponsoring clinical trial NCT00799812?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00799812 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.